| Co-Investigator(Kenkyū-buntansha) |
羽賀 博典 京都大学, 医学研究科, 教授 (10252462)
大段 秀樹 広島大学, 医系科学研究科(医), 教授 (10363061)
内田 浩一郎 順天堂大学, 健康総合科学先端研究機構, 准教授 (80648329)
江川 裕人 東京女子医科大学, 医学部, 特任教授 (40293865)
|
| Budget Amount *help |
¥46,280,000 (Direct Cost: ¥35,600,000、Indirect Cost: ¥10,680,000)
Fiscal Year 2024: ¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2023: ¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2022: ¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2021: ¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2020: ¥27,040,000 (Direct Cost: ¥20,800,000、Indirect Cost: ¥6,240,000)
|
| Outline of Final Research Achievements |
A nationwide study in Japan identified 158 liver transplant patients who maintained stable graft function without immunosuppressants for over a year. A multicenter research group investigated immune tolerance mechanisms using liver graft biopsies analyzed via immunohistochemistry, RNA sequencing, and spatial profiling. Tolerance grafts lacked inflammation and showed active regulatory T cells without exhaustion, unlike rejection samples, which had exhausted T cells. Mixed lymphocyte reactions revealed two types of donor-specific immune responses: minimal and active. Overall, the study highlights that both local and systemic immune regulation support long-term transplant tolerance.
|